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Enteritidis is the most frequent Salmonella
serovar in all regions of the United States, except
the Pacific Northwest where Typhimurium is the
most frequent. In 1996, 31.1% of all Salmonella
isolates from human sources in Washington,
Oregon, and Idaho were serovar Typhimurium,
while 14.6% were serovar Enteritidis (1).
Typhimurium is also one of the most common
Salmonella serovars from animal sources in the
United States (2).
Use of antimicrobial drugs in food animals
may lead to resistant strains of pathogens, which
may be transmitted to humans through food (3,4).
Although there is evidence that this transmis-
sion occurs, the contribution of antimicrobial use
in food animals to resistance in bacteria infecting
humans is the subject of debate (5-8).
We compared antimicrobial resistance pat-
terns of Salmonella enterica serovar
Typhimurium (ST) from human and cattle
sources over a 15-year period and examined how
these patterns relate to antimicrobial use in
livestock and humans.
The Study
We used all ST (including S. Typhimurium
var Copenhagen) isolates from clinical bovine
samples submitted to the Washington Animal
Disease Diagnostic Laboratory from 1986
through 1997 and from cattle herds tested by the
Field Disease Investigation Unit during salmo-
nellosis outbreaks over the same period (n = 378).
For herds sampled repeatedly over time, all but
the first ST isolate (per year) were excluded.
Antimicrobial resistance data were also avail-
able for ST isolates from cattle for 1982 through
1986 from clinical submissions to the Washing-
ton Animal Disease Diagnostic Laboratory.
Isolates from human clinical specimens (n = 715)
were obtained from the Washington State
Department of Health Public Health Labora-
tory for 1989, 1994, 1996, and 1997, and from
the Idaho Division of Health, Bureau of
Laboratories for 1997.
Isolates from other laboratories were
subcultured onto solid brain heart infusion agar.
All isolates were maintained in a -70º C bank
freezer in brain heart infusion broth containing
25% to 30% buffered glycerol. Isolates were
streaked for isolation on sheep blood agar prior to
susceptibility testing. Susceptibility testing for
the antimicrobial drugs listed in Table 1 was
done by a disk diffusion method (9) on
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We compared antimicrobial resistance patterns of Salmonella enterica serovar
Typhimurium (ST) of isolates from humans (n = 715) and cattle (n = 378) in the Pacific
Northwest from 1982 through 1997. The major changes in antimicrobial resistance can
be attributed to the widespread clonal dissemination of multidrug-resistant definitive
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Table 1. Resistance to individual antibiotics among Salmonella Typhimurium isolates from cattle and humans
A. From cattle
Number (%) resistant by years
1982-1985a 1986-1990 1991-1994 1995-1997
Antimicrobial drug   n = 49   n = 116   n = 90   n = 123
Ampicillin 39 (79.6)   99 (85.3) 72 (80.0) 113 (91.9)
Chloramphenicola   2 (4.1)     2 (1.7) 56 (62.2)   90 (73.2)
Gentamicin   1 (2.0)     6 (5.2) 14 (15.6)     5 (4.1)
Kanamycina   NA 103 (90.4) 49 (54.4)   50 (40.7)
Streptomycin 43 (87.8) 109 (94.0) 78 (86.7) 116 (94.3)
Tetracycline 43 (87.8) 101 (87.1) 77 (85.6) 115 (93.5)
Trimethoprim   NA     1 (0.9) 11 (12.2)     6 (4.9)
Trimethoprim-   7 (14.3)     1 (0.9) 11 (12.2)     9 (7.3)
  sulfamethoxazole
Triple sulfa  39 (79.6) 108 (93.1) 75 (83.3) 117 (95.1)
B. From humans
Number (%) resistant by year
   1989     1994     1996    1997
Antimicrobial drug   n = 90   n = 189    n = 187   n = 249
Ampicillina 22 (24.4) 107 (56.6) 109 (58.3) 164 (65.9)
Chloramphenicola   3 (3.3)   84 (44.4)   92 (49.2) 116 (46.6)
Gentamicin   2 (2.2)     5 (2.7)     5 (2.7)     2 (0.8)
Kanamycin 25 (27.8)   44 (23.3)   34 (18.2)   47 (18.9)
Streptomycina 42 (46.7) 112 (59.3) 109 (58.3) 174 (69.9)
Tetracyclinea 36 (40.0) 101 (53.4) 109 (58.3) 158 (63.5)
Trimethoprim   0     7 (5.1)     6 (3.1)     5 (2.0)
Trimethoprim-   0     6 (3.7)     6 (3.2)     5 (2.0)
  sulfamethoxazole
Triple sulfaa 36 (40.0) 123 (65.1) 143 (76.5) 231 (92.8)
aChi-square test for trend, p value <0.001.
NA, data not available.
Mueller-Hinton agar prepared according to
National Committee for Clinical Laboratory
Standards (NCCLS) guidelines (10,11).
Ciprofloxacin susceptibility was tested on a
subset of isolates systematically selected to
include five per species per year.
Data for the analysis were divided into
periods 1982-1986, 1987-1990, 1991-1994, and
1995-1997. These periods were chosen to
compare isolates from cattle with isolates from
humans for the years for which isolates from
humans were available. Each isolate was
classified as resistant or susceptible to each
antimicrobial drug tested by the threshold zone
size for resistance, as recommended by NCCLS
(10,11). The proportions of isolates resistant to
individual drugs and having each antimicrobial
resistance pattern were computed by species and
period. Significance testing of differences in
proportions was done with Epi Info (12) using the
chi-square test and the chi-square test for trend.
Marked changes in resistance to chloram-
phenicol were observed for isolates from both
cattle and humans (Tables 1, 2). Before 1991,
fewer than 5% of isolates from cattle and only 3%
of the 1989 isolates from humans were resistant
to chloramphenicol; by the mid-1990s, more than
70% (90 of 123) of isolates from cattle (p <0.01)
and almost 50% (92 of 187) of isolates from
humans (p <0.01) were resistant to chloram-
phenicol. Most (79%) isolates from cattle were
resistant to ampicillin, streptomycin, tetracy-
cline, and sulfonamides throughout the study
period. Among isolates from humans, the
proportion resistant to these drugs was
significantly lower in 1989 than in 1997
(p <0.01). The proportion of isolates from cattle
resistant to kanamycin was significantly less
(p <0.01) in 1990 to 1994 than in 1986 to 1990. All
isolates tested were susceptible to ciprofloxacin,
and average zone sizes showed no evidence of
decline during the period (data not shown).
Among isolates from both cattle and humans,
the ACSSuT resistance pattern was the most804 804 804 804 804 Emerging Infectious Diseases Vol. 5, No. 6, November–December 1999
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Table 2. Antimicrobial resistance patterns for Salmonella
Typhimurium isolates from cattle and humans
A. Cattle
Number (%)
1982- 1986- 1991- 1995-
1985a 1990 1994 1997
 n = 49 n = 114  n = 90  n = 123
ACSSuT   1 (2.0)   1 (0.9) 18 (20.0) 55 (44.7)
ACKSSuT   0 25 (27.8) 24 (19.5)
ASSuT 24 (49.0)   0   5 (5.6)   6 (4.9)
AKSSuT 83 (72.8)   4 (4.4) 14 (11.4)
Su   1 (2.0)   1 (0.9)   0   0
All Others 22 (45.0) 24 (21.1) 29 (32.2) 20 (16.2)
Susceptb   1 (2.0)   5 (4.4)   9 (10.0)   4 (3.3)
B. Humans
Number (%)
1989 1994 1996-1997
 n = 90 n = 189   n = 436
ACSSuT   2 (2.2) 44 (23.3) 156 (35.8)
ACKSSuT   0 26 (13.8)   35 (8.0)
ASSuT   0 14 (7.4)   24 (5.5)
AKSSuT 19 (21.1)   2 (1.1)   33 (7.6)
Su   1 (1.1)   9 (4.8)   80 (18.4)
All Others 25 (27.8) 33 (17.5)   47 (10.8)
Susceptb 43 (47.8) 61 (32.3)   61 (14.0)
aData on kanamycin susceptibility not available for 1982-1985.
bSusceptible to all antimicrobial drugs tested.
A, ampicillin; C, chloramphenicol; T, tetracycline; G, gentamicin;
K, kanamycin; S, streptomycin; Su, sulfonamide; Tmp,
trimethoprim.
frequent and increased in frequency over the
study period (Table 2). Before 1991, ACSSuT
accounted for fewer than 4 (2%) of 255 of isolates
from both species, and by the mid-1990s it
accounted for more than 55 (40%) of 123 of
isolates from cattle and more than 156 (35%) of
436 of isolates from humans. Isolates with the
ACSSuT resistance pattern together with
ACKSSuT-resistant isolates accounted for 79
(64%) of 123 isolates from cattle and 191 (44%) of
436 isolates from humans by the mid-1990s. As
previously reported, 57 (95%) of 60 of these isolates
were phage typed and found to be DT104 with a
single pulsed-field gel electrophoresis pattern (13).
Isolates susceptible to all drugs tested were
more common from human than cattle sources
(166 [23.2%] of 715 vs. 19 [5.0%] of 378, p <0.01).
The proportion of isolates from humans
susceptible to all drugs tested decreased
substantially from 1989 to 1997 (chi-square
test for trend, p <0.01), while that of isolates
from cattle was 10% or less for all periods
studied (Table 2).
Conclusions
Antimicrobial resistance has been commonly
observed in human and bovine ST isolates since
the earliest days of antimicrobial use. This study
provides a longitudinal perspective on resistance
in ST from cattle and humans in a region and
allows insight as to the mechanism of changes in
antimicrobial resistance. The greatest changes
were in chloramphenicol and kanamycin
resistance in isolates from cattle and ampicillin,
chloramphenicol, streptomycin, sulfonamides,
and tetracycline resistance in isolates from
humans. Changes in resistance in isolates from
both species were primarily due to the sharply
increased occurrence of isolates displaying the
ACSSuT resistance pattern, a reliable marker
for multidrug-resistant definitive type 104 ST
(MR-DT104) (14). This has been shown to be so in
the Pacific Northwest through a subset of
isolates from this study (13).
MR-DT104 was first detected almost simul-
taneously in several geographic areas, including
the United Kingdom (15), the United States (13),
and Canada (16). Molecular genetic studies
indicate that the same gene cassette accounts for
multiple resistance in isolates from these and
other diverse geographic areas (17,18). This
study not only provides supporting evidence that
MR-DT104 from different regions are clonal in
origin, but refutes the notion that the multiple
antimicrobial resistance of this clone was due to
acquisition of new resistance genes by indig-
enous ST in each region.
It is possible that local antimicrobial
selection pressure played an important role in
dissemination of MR-DT104 through cattle
populations into the human population. How-
ever, several observations argue against this
hypothesis. First, the rise in the percentage of
resistance to chloramphenicol in isolates from
cattle occurred after the withdrawal of the drug
for use in food animals in the mid-1980s (19) and
before the 1996 approval of florfenicol (a
chloramphenicol analog that shares resistance
loci with chloramphenicol in MR-DT104 [20]) for
therapeutic use in cattle. Second, before the
dissemination of MR-DT104, most isolates from
cattle were resistant to ampicillin, streptomycin,
sulfonamides, and tetracycline. It is not evident
how, in the absence of chloramphenicol use,
antimicrobial selection pressure would favor R-
type ACSSuT over ASSuT, although it is possible805 805 805 805 805 Vol. 5, No. 6, November–December 1999 Emerging Infectious Diseases
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that an unmeasured resistance factor favored
the dissemination of MR-DT104 over ASSuT
strains. Third, early in its global dissemination,
MR-DT104 was isolated from several species of
wildlife, which are not exposed to substantial
amounts of antimicrobial drugs (13). Finally,
reports of broad dissemination of Salmonella
clones susceptible to antimicrobial drugs com-
monly used in livestock provide evidence that
agent factors other than antimicrobial resistance
are necessary for broad dissemination (21,22).
Nevertheless, some selection pressure that
likely involved antimicrobial use must explain
the high prevalence of antimicrobial resistance
among ST. There is strong evidence that
livestock are the main reservoir for human
salmonellosis in industrialized countries (23);
however, it would be an error to assume that the
emergence of a globally disseminated clone can
be attributed to antimicrobial use in livestock. A
human reservoir exists for nontyphoidal Salmo-
nella, including serovar Typhimurium, in
developing countries (24,25), and there is strong
evidence that antimicrobial use in humans has
not only driven the emergence of multidrug-
resistant clones in these regions but has resulted
in an increasingly high prevalence of multiple
resistance (26-29). Dissemination of multidrug-
resistant Salmonella from developing countries,
through human traffic, is well documented
(30,31) and seems a more likely mode of
international transport than the far more limited
international livestock traffic.
Multidrug-resistant clones capable of global
dissemination can emerge as a result of
antimicrobial selection pressure in either
livestock or humans; simply restricting antimi-
crobial use in livestock populations cannot
prevent broad dissemination. The problem of
globally distributed multidrug-resistant bacte-
rial clones can be compared to the nosocomial
scenario: prudent antimicrobial use is a sensible
step, but the main effort must go toward
preventing dissemination if the program is to be
effective.
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